STOCK TITAN

PTC Therapeutics to Present at the Jefferies Virtual Gene Therapy/Editing Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

PTC Therapeutics, Inc. (NASDAQ: PTCT) will present a company overview on October 1, 2020, at the Jefferies Virtual Gene Therapy/Editing Summit at 9:00 a.m. ET. The presentation will be live-streamed on their website and available for 30 days afterward. PTC Therapeutics focuses on developing medicines for rare disorders, aiming to provide access to innovative treatments for patients with unmet needs. For optimal viewing, it's recommended to connect a few minutes before the start of the webcast.

Positive
  • None.
Negative
  • None.

SOUTH PLAINFIELD, N.J., Sept. 24, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the Jefferies Virtual Gene Therapy/Editing Summit on Thursday, October 1st at 9:00 a.m. ET.

The presentation will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

FOR MORE INFORMATION PLEASE CONTACT:

Media:    

Investors:

Jane Baj  

Lisa Hayes

+1 (908) 912-9167    

+1 (908) 868-8926

jbaj@ptcbio.com          

lhayes@ptcbio.com 

Cision View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-at-the-jefferies-virtual-gene-therapyediting-summit-301137035.html

SOURCE PTC Therapeutics, Inc.

FAQ

When is PTC Therapeutics presenting at the Jefferies Virtual Gene Therapy/Editing Summit?

PTC Therapeutics will present on October 1, 2020, at 9:00 a.m. ET.

Where can I watch the PTC Therapeutics presentation from the Jefferies Summit?

The presentation can be watched live on the PTC Therapeutics website in the investor relations section.

How long will the PTC Therapeutics presentation be available online?

The presentation will be archived for 30 days following the event.

What is the focus of PTC Therapeutics as a biopharmaceutical company?

PTC Therapeutics is focused on developing clinically differentiated medicines for rare disorders.

What is the stock symbol for PTC Therapeutics?

The stock symbol for PTC Therapeutics is PTCT.

PTC Therapeutics, Inc.

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Stock Data

3.39B
77.13M
2.34%
105.79%
6.06%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WARREN